Free Trial

HighTower Advisors LLC Buys 10,585 Shares of The Clorox Company (NYSE:CLX)

Clorox logo with Consumer Staples background
Remove Ads

HighTower Advisors LLC grew its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 2.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 395,445 shares of the company's stock after buying an additional 10,585 shares during the quarter. HighTower Advisors LLC owned 0.32% of Clorox worth $64,224,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. State Street Corp grew its stake in shares of Clorox by 3.1% in the third quarter. State Street Corp now owns 8,182,109 shares of the company's stock worth $1,332,947,000 after purchasing an additional 245,525 shares during the last quarter. Mizuho Securities USA LLC grew its stake in shares of Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock worth $733,095,000 after purchasing an additional 4,490,421 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Clorox by 1.1% in the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company's stock worth $491,713,000 after purchasing an additional 33,970 shares during the last quarter. Stifel Financial Corp grew its stake in shares of Clorox by 1.7% in the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company's stock worth $380,370,000 after purchasing an additional 37,967 shares during the last quarter. Finally, Amundi grew its stake in shares of Clorox by 42.6% in the fourth quarter. Amundi now owns 1,032,283 shares of the company's stock worth $165,816,000 after purchasing an additional 308,234 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Remove Ads

Analyst Upgrades and Downgrades

Several research firms recently issued reports on CLX. Barclays raised their target price on Clorox from $130.00 to $140.00 and gave the stock an "underweight" rating in a research note on Wednesday, February 5th. Royal Bank of Canada reissued a "sector perform" rating and issued a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Evercore ISI raised their price objective on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. JPMorgan Chase & Co. raised their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a report on Tuesday, February 4th. Finally, Wells Fargo & Company raised their price objective on shares of Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $159.62.

Check Out Our Latest Analysis on CLX

Clorox Stock Up 0.3 %

Shares of CLX stock traded up $0.37 during trading hours on Friday, hitting $147.32. 1,035,843 shares of the company's stock traded hands, compared to its average volume of 1,217,296. The stock's fifty day simple moving average is $154.20 and its two-hundred day simple moving average is $160.20. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The stock has a market cap of $18.15 billion, a price-to-earnings ratio of 40.25, a PEG ratio of 2.62 and a beta of 0.45. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the business earned $2.16 earnings per share. On average, analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a $1.22 dividend. The ex-dividend date of this dividend is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.31%. Clorox's payout ratio is currently 133.33%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads